Eidel Jeff Insider Trades

Insider Trading History

Track insider trading activity for Eidel Jeff. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $1.37M 869,730 shares
Last Trade
Aug 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.5k 26,760 shares
$1.59
$1.58
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $1.41M 893,362 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 461,538 shares
$5.13
$1.58
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $682k 431,824 shares
Last Trade
Feb 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$92.4k 15,498 shares
$5.96
$1.58
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $703k 444,666 shares
Last Trade
Aug 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$275k 25,936 shares
$10.60
$1.58
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $744k 470,602 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 164,200 shares
$9.43
$1.58
Pacific Biosciences of California
Pacific Biosciences of California PACB
See Remarks
Holding Value $948k 600,000 shares
Last Trade
Aug 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.8M 600,000 shares
$8.00
$1.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up